Cerebral amyloid angiopathy (CAA) is an age-related small-vessel disease and the leading cause of spontaneous lobar brain hemorrhage in older adults. The 2023 China consensus gives 14 evidence-based recommendations on diagnosis, prevention, and management.
“Cerebral Amyloid Angiopathy: 2023 China Consensus Explained” is part of iMedCompanion’s plain-language library for international patients travelling to China for care. It explains what usually happens, what to prepare, and where to find related specialists and hospitals.
No. It explains what usually happens so you can ask better questions; decisions are made with your own specialist.
The guides are published in English; interpretation and translation are arranged as a separate service.
Each guide links to related specialists and hospitals, or you can send an enquiry and a medical advisor will match you.
Acute ischemic stroke is ~80% of strokes in China. The 2024 reperfusion guideline expands eligibility for intravenous thrombolysis and…
What happens in the first hours and weeks after a stroke, and how rehabilitation is structured for patients who plan to return home abroad.
Why a "superficial" bladder tumour is not the end of treatment, how risk is stratified, what BCG and intravesical chemotherapy do, and how…
